Your browser doesn't support javascript.
loading
Characterization of Recessive Parkinson Disease in a Large Multicenter Study.
Lesage, Suzanne; Lunati, Ariane; Houot, Marion; Romdhan, Sawssan Ben; Clot, Fabienne; Tesson, Christelle; Mangone, Graziella; Toullec, Benjamin Le; Courtin, Thomas; Larcher, Kathy; Benmahdjoub, Mustapha; Arezki, Mohamed; Bouhouche, Ahmed; Anheim, Mathieu; Roze, Emmanuel; Viallet, François; Tison, François; Broussolle, Emmanuel; Emre, Murat; Hanagasi, Hasmet; Bilgic, Basar; Tazir, Meriem; Djebara, Mouna Ben; Gouider, Riadh; Tranchant, Christine; Vidailhet, Marie; Le Guern, Eric; Corti, Olga; Mhiri, Chokri; Lohmann, Ebba; Singleton, Andrew; Corvol, Jean-Christophe; Brice, Alexis.
Afiliação
  • Lesage S; Research Unit UMR 1127, Sorbonne University, Paris, France.
  • Lunati A; Research Unit U1127, National Institute of Health and Medical Research, Paris, France.
  • Houot M; Research Unit UMR 7225, the French National Center for Scientific Research, Paris, France.
  • Romdhan SB; Institute for Brain and Spinal Cord, Paris, France.
  • Clot F; Research Unit UMR 1127, Sorbonne University, Paris, France.
  • Tesson C; Research Unit U1127, National Institute of Health and Medical Research, Paris, France.
  • Mangone G; Research Unit UMR 7225, the French National Center for Scientific Research, Paris, France.
  • Toullec BL; Institute for Brain and Spinal Cord, Paris, France.
  • Courtin T; Institute of Memory and Alzheimer's Disease, Center of Excellence for Neurodegenerative Diseases, Public Hospital Network of Paris, Department of Neurology, Pitié-Salpêtrière Hospital, University of Paris 6, Paris, France.
  • Larcher K; Clinical Investigation Center, Pitié Neurosciences CIC-1422, Paris, France.
  • Benmahdjoub M; Research Unit UMR 1127, Sorbonne University, Paris, France.
  • Arezki M; Research Unit U1127, National Institute of Health and Medical Research, Paris, France.
  • Bouhouche A; Research Unit UMR 7225, the French National Center for Scientific Research, Paris, France.
  • Anheim M; Institute for Brain and Spinal Cord, Paris, France.
  • Roze E; Research Unit in Neurogenetics, Clinical Investigation Center, Habib Bourguiba University Hospital Center, Sfax, Tunisia.
  • Viallet F; Functional Unit of Molecular and Cellular Neurogenetics, Department of Genetics, Public Hospital Network of Paris, University Hospitals of La Pitié Salpêtrière-Charles Foix, Paris, France.
  • Tison F; Research Unit UMR 1127, Sorbonne University, Paris, France.
  • Broussolle E; Research Unit U1127, National Institute of Health and Medical Research, Paris, France.
  • Emre M; Research Unit UMR 7225, the French National Center for Scientific Research, Paris, France.
  • Hanagasi H; Institute for Brain and Spinal Cord, Paris, France.
  • Bilgic B; Clinical Investigation Center, Pitié Neurosciences CIC-1422, Paris, France.
  • Tazir M; Clinical Investigation Center, Pitié Neurosciences CIC-1422, Paris, France.
  • Djebara MB; Research Unit UMR 1127, Sorbonne University, Paris, France.
  • Gouider R; Research Unit U1127, National Institute of Health and Medical Research, Paris, France.
  • Tranchant C; Research Unit UMR 7225, the French National Center for Scientific Research, Paris, France.
  • Vidailhet M; Institute for Brain and Spinal Cord, Paris, France.
  • Le Guern E; Functional Unit of Molecular and Cellular Neurogenetics, Department of Genetics, Public Hospital Network of Paris, University Hospitals of La Pitié Salpêtrière-Charles Foix, Paris, France.
  • Corti O; Frantz Fanon Hospital, University Hospital Center of Blida, Blida, Algeria.
  • Mhiri C; Frantz Fanon Hospital, University Hospital Center of Blida, Blida, Algeria.
  • Lohmann E; Research Unit in Neurology and Neurogenetics, Department of Neurology B and Neurogenetics, Faculty of Medicine and Pharmacy, Specialty Hospital ONO, Mohammed V University, Rabat, Morocco.
  • Singleton A; Department of Neurology, University Hospitals of Strasbourg, Strasbourg, France.
  • Corvol JC; Institute of Genetics and Molecular and Cellular Biology, Illkirch, France.
  • Brice A; Federation of Translational Medicine of Strasbourg, University of Strasbourg, Strasbourg, France.
Ann Neurol ; 88(4): 843-850, 2020 10.
Article em En | MEDLINE | ID: mdl-33045815
Studies of the phenotype and population distribution of rare genetic forms of parkinsonism are required, now that gene-targeting approaches for Parkinson disease have reached the clinical trial stage. We evaluated the frequencies of PRKN, PINK1, and DJ-1 mutations in a cohort of 1,587 cases. Mutations were found in 14.1% of patients; 27.6% were familial and 8% were isolated. PRKN was the gene most frequently mutated in Caucasians, whereas PINK1 mutations predominated in Arab-Berber individuals. Patients with PRKN mutations had an earlier age at onset, and less asymmetry, levodopa-induced motor complications, dysautonomia, and dementia than those without mutations. ANN NEUROL 2020;88:843-850.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Proteínas Quinases / Ubiquitina-Proteína Ligases / Proteína Desglicase DJ-1 Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Neurol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Proteínas Quinases / Ubiquitina-Proteína Ligases / Proteína Desglicase DJ-1 Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Neurol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França